Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WelChol Add-on to Sulfonylurea in T2D
NCT00147758Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2004
- Primary completion
- Aug 2006
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of colesevelam in type 2 diabetes mellitus (T2DM), sponsored by Daiichi Sankyo Co., Ltd.. Started Jun 2004; status: completed.
02
Drugs
colesevelam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00147758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147758.